Neurodegeneration caused by proteins with an aberrant carboxyl-terminus

Ruben Vidal, Marie Bernadette Delisle, Bernardino Ghetti

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

In recent years, 2 groups of hereditary neurodegenerative diseases have been recognized in which different genetic defects lead to the accumulation of proteins that contain a carboxyl-terminus that is abnormal in length and primary sequence. In this paper, we review the current knowledge on the molecular basis of diseases from these 2 groups. The first group includes familial British and Danish dementias, in which the molecular genetic defect resides in the BRI 2 gene located on chromosome 13. In this group, carboxyl-terminal proteolytic products of the mutant BRI2 proteins aggregate in the extracellular space of the brain and in blood vessels. The second group includes 2 recently described ferritinopathies, in which the molecular genetic defect resides in the ferritin light polypeptide gene located on chromosome 19. In this group, full-length ferritin polypeptides aggregate intracellularly. The study of these conditions has led to the discovery of the BRI2 gene and to the finding of an unsuspected role for ferritin in neurodegeneration. These diseases provide new models in which to study the relationship between abnormal protein aggregation, neuronal cell death, and dementia.

Original languageEnglish
Pages (from-to)787-800
Number of pages14
JournalJournal of Neuropathology and Experimental Neurology
Volume63
Issue number8
StatePublished - Aug 2004

Fingerprint

Ferritins
Nervous System Heredodegenerative Disorders
Molecular Biology
Chromosomes, Human, Pair 19
Chromosomes, Human, Pair 13
Peptides
Proteins
Extracellular Space
Genetic Association Studies
Mutant Proteins
Genes
Blood Vessels
Dementia
Cell Death
Light
Brain

Keywords

  • ABri
  • ADan
  • Amyloid
  • Ferritin
  • Inclusion bodies
  • Neurodegeneration

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Neuroscience(all)

Cite this

Neurodegeneration caused by proteins with an aberrant carboxyl-terminus. / Vidal, Ruben; Delisle, Marie Bernadette; Ghetti, Bernardino.

In: Journal of Neuropathology and Experimental Neurology, Vol. 63, No. 8, 08.2004, p. 787-800.

Research output: Contribution to journalArticle

@article{2ada6a60209f40a0bc584e32920c530c,
title = "Neurodegeneration caused by proteins with an aberrant carboxyl-terminus",
abstract = "In recent years, 2 groups of hereditary neurodegenerative diseases have been recognized in which different genetic defects lead to the accumulation of proteins that contain a carboxyl-terminus that is abnormal in length and primary sequence. In this paper, we review the current knowledge on the molecular basis of diseases from these 2 groups. The first group includes familial British and Danish dementias, in which the molecular genetic defect resides in the BRI 2 gene located on chromosome 13. In this group, carboxyl-terminal proteolytic products of the mutant BRI2 proteins aggregate in the extracellular space of the brain and in blood vessels. The second group includes 2 recently described ferritinopathies, in which the molecular genetic defect resides in the ferritin light polypeptide gene located on chromosome 19. In this group, full-length ferritin polypeptides aggregate intracellularly. The study of these conditions has led to the discovery of the BRI2 gene and to the finding of an unsuspected role for ferritin in neurodegeneration. These diseases provide new models in which to study the relationship between abnormal protein aggregation, neuronal cell death, and dementia.",
keywords = "ABri, ADan, Amyloid, Ferritin, Inclusion bodies, Neurodegeneration",
author = "Ruben Vidal and Delisle, {Marie Bernadette} and Bernardino Ghetti",
year = "2004",
month = "8",
language = "English",
volume = "63",
pages = "787--800",
journal = "American Journal of Psychotherapy",
issn = "0002-9564",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Neurodegeneration caused by proteins with an aberrant carboxyl-terminus

AU - Vidal, Ruben

AU - Delisle, Marie Bernadette

AU - Ghetti, Bernardino

PY - 2004/8

Y1 - 2004/8

N2 - In recent years, 2 groups of hereditary neurodegenerative diseases have been recognized in which different genetic defects lead to the accumulation of proteins that contain a carboxyl-terminus that is abnormal in length and primary sequence. In this paper, we review the current knowledge on the molecular basis of diseases from these 2 groups. The first group includes familial British and Danish dementias, in which the molecular genetic defect resides in the BRI 2 gene located on chromosome 13. In this group, carboxyl-terminal proteolytic products of the mutant BRI2 proteins aggregate in the extracellular space of the brain and in blood vessels. The second group includes 2 recently described ferritinopathies, in which the molecular genetic defect resides in the ferritin light polypeptide gene located on chromosome 19. In this group, full-length ferritin polypeptides aggregate intracellularly. The study of these conditions has led to the discovery of the BRI2 gene and to the finding of an unsuspected role for ferritin in neurodegeneration. These diseases provide new models in which to study the relationship between abnormal protein aggregation, neuronal cell death, and dementia.

AB - In recent years, 2 groups of hereditary neurodegenerative diseases have been recognized in which different genetic defects lead to the accumulation of proteins that contain a carboxyl-terminus that is abnormal in length and primary sequence. In this paper, we review the current knowledge on the molecular basis of diseases from these 2 groups. The first group includes familial British and Danish dementias, in which the molecular genetic defect resides in the BRI 2 gene located on chromosome 13. In this group, carboxyl-terminal proteolytic products of the mutant BRI2 proteins aggregate in the extracellular space of the brain and in blood vessels. The second group includes 2 recently described ferritinopathies, in which the molecular genetic defect resides in the ferritin light polypeptide gene located on chromosome 19. In this group, full-length ferritin polypeptides aggregate intracellularly. The study of these conditions has led to the discovery of the BRI2 gene and to the finding of an unsuspected role for ferritin in neurodegeneration. These diseases provide new models in which to study the relationship between abnormal protein aggregation, neuronal cell death, and dementia.

KW - ABri

KW - ADan

KW - Amyloid

KW - Ferritin

KW - Inclusion bodies

KW - Neurodegeneration

UR - http://www.scopus.com/inward/record.url?scp=3843069669&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3843069669&partnerID=8YFLogxK

M3 - Article

C2 - 15330334

AN - SCOPUS:3843069669

VL - 63

SP - 787

EP - 800

JO - American Journal of Psychotherapy

JF - American Journal of Psychotherapy

SN - 0002-9564

IS - 8

ER -